J
Joseph S. Bresee
Researcher at Centers for Disease Control and Prevention
Publications - 261
Citations - 35039
Joseph S. Bresee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Vaccination. The author has an hindex of 78, co-authored 255 publications receiving 32225 citations. Previous affiliations of Joseph S. Bresee include National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010–19: a retrospective analysis
Ledor S. Igboh,Katherine Roguski,Perrine Marcenac,Gideon O. Emukule,Myrna Charles,Stefano Tempia,Belinda L. Herring,Katelijn Vandemaele,Ann Moen,Sonja J. Olsen,David E. Wentworth,Rebecca Kondor,Joshua A. Mott,Siddhivinayak Hirve,Joseph S. Bresee,Punam Mangtani,Patrick Nguipdop-Djomo,Eduardo Azziz-Baumgartner +17 more
TL;DR: In this article , a 3-week moving proportion of samples positive for influenza virus and assessed epidemic timing using an aggregate average method was calculated, defined as the first week when the proportion of positive samples exceeded or went below the annual mean, respectively, for at least 3 consecutive weeks.
Journal ArticleDOI
Mortalidad asociada a la gripe en 2009 en cuatro sitios centinela en Bangladesh
Nusrat Homaira,Stephen P. Luby,Asm Alamgir,Kariul Islam,Repon C. Paul,Jaynal Abedin,Mustafizur Rahman,Tasnim Azim,Goutam Podder,Badrul Munir Sohel,Abdullah Brooks,Alicia M. Fry,Marc-Alain Widdowson,Joseph S. Bresee,Mahmudur Rahman,Eduardo Azziz-Baumgartner +15 more
TL;DR: In this article, the authors used a combination of hospital-based influenza surveillance and community surveys to estimate influenza-associated mortality in Bangladesh in 2009, and they assumed that the corresponding rate in Bangladesh would be about the same, at 10 deaths per 100 000.
Journal ArticleDOI
Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
Chelsea S. Lutz,Matthew Biggerstaff,Melissa A Rolfes,Kathryn E. Lafond,Eduardo Azziz-Baumgartner,Rachael M. Porter,Carrie Reed,Joseph S. Bresee +7 more
TL;DR: In this paper, the authors evaluated the potential benefits of earlier vaccine availability, and estimated the number of illnesses and deaths that could be averted during a 2009-like influenza pandemic under five different vaccine availability timing scenarios.
Journal ArticleDOI
Estimated mortality due to seasonal influenza in southeast of Iran, 2006/2007 to 2011/2012 influenza seasons
Razieh Khajehkazemi,Mohammad Reza Baneshi,A. Danielle Iuliano,Katherine Roguski,Hamid Sharifi,Joseph S. Bresee,Ali Akbar Haghdoost +6 more
TL;DR: The findings help to define the mortality burden of seasonal influenza, most of which affects adults aged ≥75 years, and supports influenza prevention and vaccination programs in older adults.
Posted ContentDOI
Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2021
Radhika Gharpure,Anna N. Chard,Maria A. Cabrera Escobar,Wen-yu Zhou,Joseph S. Bresee,Eduardo Azziz-Baumgartner,Sarah Wood Pallas,Kathryn E. Lafond +7 more
TL;DR: In this article , a systematic review of economic evaluations describing costs of influenza illness, costs of vaccination programs, and vaccination cost-effectiveness from low and middle-income countries to assess if gaps persist.